Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Publications from the Centre for Immuno-Oncology

Integrating Patient and Public Involvement and Engagement in Translational Medicine

Borrow P. et al, (2024), The Lancet

A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing

Hwang JK. et al, (2024)

MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer.

Liao H. et al, (2024), Nat Commun, 15

The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.

Brackenridge S. et al, (2024), Frontiers in immunology, 15

Inhibition of salt inducible kinases reduces rhythmic HIV-1 replication and reactivation from latency.

Borrmann H. et al, (2023), The Journal of general virology, 104

Intracellular trafficking of HLA-E and its regulation.

He W. et al, (2023), The Journal of experimental medicine, 220

Molecular components of the circadian clock regulate HIV-1 replication.

Borrmann H. et al, (2023), iScience, 26

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation.

Yang H. et al, (2023), Science immunology, 8

Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.

Haynes BF. et al, (2023), Nature reviews. Immunology, 23

Human T follicular regulatory cells with helper and regulatory lineage origins

Nguyen Q. and Borrow P., (2023), Nature Reviews Immunology, 23, 204 - 204

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.

Haynes BF. et al, (2023), Nature reviews. Immunology, 23, 142 - 158

Circadian regulation of human immunodeficiency virus type 1 replication

Borrmann H. et al, (2022)

Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.

Chikata T. et al, (2022), Journal of virology, 96

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.

Li D. et al, (2022), Communications biology, 5

Graft Versus Leukaemia (GvL): Identification & Characterisation of Alloreactive Antigens and Cognate T Cell Responses in Acute Myeloid Leukemia

Sweeney C. et al, (2022), BLOOD, 140, 1576 - 1578

HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes.

Karnaukhov V. et al, (2022), Frontiers in immunology, 13

Mapping the epitopes of the Human Leukocyte Antigen E antibodies 3D12 and 4D12

Brackenridge S. et al, (2022)

Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus rh67 proteins

Brackenridge S. et al, (2022)

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial

Campion SL. et al, (2021), Journal of Clinical Investigation, 131

A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.

Hassan AS. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73, 832 - 841

Load More

1
2
3
4
5
6
7
...
»